Acne Medication Market to get significant proceeds by 2024

Acne Medication Market report offers in-depth analysis of the industry size, share, major segments, and different geographic regions, forecast for the next five years, key market players, and premium industry trends. It also focuses on the key drivers, restraints, opportunities and industry challenges.

Global acne medication market size is anticipated to expand at a considerable pace owing to rising concern for facial aesthetics and high incidences of skin infections or acne with increased severity.

Request for a sample copy of this report @

As per Global Market Insights, Inc. estimates, the global acne medication market size is expected to exceed $7 billion by 2024.

However, adverse events associated with the consumption of acne medication are likely to impede the industry dynamics over the projected timeframe.

Common side-effects of the tropical drugs include skin dryness and irritation. On the other hand, side-effects in consuming the oral drugs are upset stomach, lightheadedness, dizziness, and others.

In terms of segmentation by formulation, the global acne medication industry from the topical segment recorded revenue worth $2.9 billion in 2017. Topical acne products include gels and creams that contain benzoyl peroxide, salicylic acid, and antibiotics.

By product, the azelaic acid segment is poised to exhibit a CAGR of 7.6% through 2024. This segmental growth can be credited to rising cases of mild to moderate acne vulgaris. Myriad benefits displayed by the usage of this product include reduction of acne blemishes, inflammation & pore blockages and improvement of the post-inflammatory hyperpigmentation. These high product benefits will drive the overall acne medication market growth in the coming years.

The OTC acne medication segment registered a remuneration worth $2.4 billion in 2017, owing to accelerating development and availability of OTC drugs as well as rising number of people with mild to moderate acne.

The acne medication market from the 10-16 years segment is anticipated to expand at a CAGR of 6.8% through 2024, owing to hormonal stimulation and adolescent puberty, which leads to the enlargement of oil glands and the subsequent production of more sebum or oil.

Request for customization @

According to a recent study, over 85% of teenagers face common skin problems due to acne, which will amplify the acne medication market expansion over the estimated timeline.

On the regional front, the U.S. held a dominant position in the North America acne medication market and registered revenue worth nearly $2.3 billion in 2017.

The region will witness a rapid surge in demand for acne medication due to changing eating habits, high consumption of fast-foods, and usage of harmful makeup products by a large number of Americans.

Partial Chapter of the Table of Content

Chapter 2.     Executive Summary

2.1. Acne medication industry 3600 synopsis, 2013 – 2024

2.1.1.  Business trends

2.1.2.  Formulation trends

2.1.3.  Product trends

2.1.4.  Type trends

2.1.5.  Age group trends

2.1.6.  Regional trends

Chapter 3.     Acne Medication Industry Insights

3.1. Industry segmentation

3.2. Industry landscape, 2013 – 2024

3.3. Industry impact forces

3.3.1.  Growth drivers  Increasing prevalence of severe acne problems in North America  Growing awareness regarding the treatment options in Asia Pacific  Rising concern for facial aesthetics in Latin America

3.3.2.  Industry pitfalls & challenges  Side-effects associated with acne medication    Entry of generic products

3.4. Growth potential analysis

3.4.1.  By formulation

3.4.2.  By product

3.4.3.  By type

3.4.4.  By age group

3.5. Regulatory Landscape

3.6. Global prevalence of acne, 2017

3.7. Porter’s analysis

3.8. Competitive landscape, 2017

3.8.1.   Business overview

3.8.2.  Revenue analysis

3.8.3.  Product landscape

3.8.4.  Strategy dashboard

3.9. PESTEL analysis

Browse full table of contents (TOC) of this report @